Uğur Şahin

Uğur Şahin, one of BioNTech's co-founders, has announced that their company's cancer treatment medicine will hit the shelves as early as 2026.

Şahin, who has been working with his wife Dr. Özlem Türeci for many years on treatments targeting various types of cancers, especially bowel cancer, stated that the drugs they have developed could be on the market in a few years.

Turkey's Health Minister Fahrettin Koca has urged people to get Turkovac shots, the locally developed vaccine against COVICD-19, saying that it is already available in all 81 provinces of the county.

Two Turkish-German scientists were awarded Greece's Empress Theophano Prize on Oct. 13 for saving millions of lives with the development of the first vaccine against the coronavirus, according to the Empress Theophano Foundation. 

A new formulation is likely to be needed by the middle of next year to protect against COVID-19 as it mutates, Uğur Şahin, the chief executive of BioNTech that is behind one of the first mRNA vaccines against the coronavirus, has told the Financial Times.

The Germany-based BioNTech developed the COVID-19 vaccine jointly with the U.S. pharmaceutical company Pfizer.

The first generation vaccine developed by BioNTech-Pfizer works against coronavirus variants such as the Delta strain and does not need to be modified for the moment, the chief executive of German company BioNTech said on Aug. 9.

class='cf'>

With the administration of more than 5.3 million doses of COVID-19 jabs over the past week alone, a little over 25 percent of Turkey's population aged over 18 is now fully inoculated.

With the administration of more than 5.3 million doses of COVID-19 jabs over the past week alone, a little over 25 percent of Turkey's population is now fully inoculated.

Turkey's COVID-19 vaccine candidate has reached its final stage of human trials, Health Minister Fahrettin Koca has said as the country is gearing up to give a boost to its inoculation drive.

Turkey will receive 12 million doses of a COVID-19 vaccine developed by Pfizer/BioNTech by the end of next week, the country's health minister has said.

Fahrettin Koca said he spoke with Uğur Şahin, the co-founder of CEO of Germany-based BioNTech, earlier this week and that Şahin confirmed that they obtained export permission for 12 million doses of the injection.

Turkey on May 20 saw fewer than 10,000 new COVID-19 daily cases for the first time since March 1, said the country's health minister, marking a key milestone in the country's fight against coronavirus.